Mediar Therapeutics
Scientific Leader in the field of inflammation, autoimmunity and fibrosis with depth of industry experience in translational research and drug development. Proven success initiating and advancing programs from early research through clinical development. Strong leadership skills, with strength in setting research strategy for multi-disciplinary teams of scientists and academic collaborators.
This person is not in the org chart
Mediar Therapeutics
Mediar Therapeutics is a preclinical stage biotechnology company developing antibody-based therapeutics to halt fibrosis in a variety of organ systems, including lung, liver, kidney, and skin.